Teladoc Health, Inc. (NYSE:TDOC) Receives $7.43 Consensus Price Target from Analysts

Posted by Geri Gentry on Jun 16th, 2026

Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) has been assigned a consensus rating of “Hold” from the seventeen ratings firms that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, eleven have assigned a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $7.4333.

Several equities analysts have weighed in on TDOC shares. Barclays dropped their price objective on Teladoc Health from $8.50 to $7.00 and set an “equal weight” rating for the company in a report on Thursday, March 26th. Citigroup lifted their price target on Teladoc Health from $6.00 to $7.00 and gave the company a “neutral” rating in a research note on Tuesday, May 5th. Weiss Ratings upgraded Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, May 22nd. Canaccord Genuity Group cut their price objective on Teladoc Health from $12.00 to $10.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Finally, Deutsche Bank Aktiengesellschaft raised Teladoc Health from a “hold” rating to a “buy” rating and set a $11.00 price objective on the stock in a report on Tuesday, March 10th.

View Our Latest Stock Analysis on TDOC

Insider Transactions at Teladoc Health

In related news, insider Carlos Nueno sold 6,196 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total transaction of $47,275.48. Following the sale, the insider owned 57,671 shares of the company’s stock, valued at $440,029.73. This trade represents a 9.70% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Fernando M. Rodrigues sold 5,677 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total value of $43,315.51. Following the sale, the insider directly owned 9,572 shares in the company, valued at approximately $73,034.36. This trade represents a 37.23% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders sold 39,870 shares of company stock worth $302,507. Insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

Several hedge funds have recently modified their holdings of TDOC. Jupiter Asset Management Ltd. boosted its holdings in shares of Teladoc Health by 293.9% during the 4th quarter. Jupiter Asset Management Ltd. now owns 3,860,076 shares of the health services provider’s stock valued at $27,021,000 after acquiring an additional 2,880,008 shares in the last quarter. Quantinno Capital Management LP grew its position in shares of Teladoc Health by 128.0% in the 1st quarter. Quantinno Capital Management LP now owns 2,621,378 shares of the health services provider’s stock valued at $14,287,000 after buying an additional 1,471,631 shares during the last quarter. Pale Fire Capital SE grew its position in shares of Teladoc Health by 74.8% in the 1st quarter. Pale Fire Capital SE now owns 3,398,491 shares of the health services provider’s stock valued at $18,522,000 after buying an additional 1,454,288 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of Teladoc Health by 23.8% in the 3rd quarter. Dimensional Fund Advisors LP now owns 6,889,194 shares of the health services provider’s stock valued at $53,260,000 after buying an additional 1,325,106 shares during the last quarter. Finally, Trexquant Investment LP bought a new stake in shares of Teladoc Health in the 4th quarter valued at about $9,156,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Price Performance

Shares of NYSE TDOC opened at $7.46 on Thursday. The firm has a market cap of $1.35 billion, a P/E ratio of -7.69 and a beta of 2.14. The company has a current ratio of 2.80, a quick ratio of 2.72 and a debt-to-equity ratio of 0.75. Teladoc Health has a 1-year low of $4.40 and a 1-year high of $9.77. The business’s 50 day moving average is $6.42 and its 200-day moving average is $6.22.

Teladoc Health (NYSE:TDOC – Get Free Report) last announced its earnings results on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.01). The firm had revenue of $613.85 million for the quarter, compared to the consensus estimate of $611.04 million. Teladoc Health had a negative return on equity of 11.45% and a negative net margin of 6.81%.Teladoc Health’s revenue for the quarter was down 2.5% on a year-over-year basis. During the same quarter last year, the business posted ($0.53) EPS. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. Equities research analysts predict that Teladoc Health will post -0.92 earnings per share for the current year.

Teladoc Health Company Profile

(Get Free Report)

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.